Aralez Announces Board Member Resignation

MISSISSAUGA, Ontario, June 7, 2017 /CNW/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) (the "Company") today announced it received a written letter of resignation from Jason M. Aryeh stating that he resigned, effective immediately, from his position on the Board of Directors of the Company.  Mr. Aryeh did not resign as a result of any current dispute or disagreement with the Company. Mr. Aryeh was a valued member of the Board during the period he served as a director.

About Aralez Pharmaceuticals Inc. 
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in Mississauga, Ontario, Canada, its U.S. Headquarters is in Princeton, New Jersey and its Ireland Headquarters is in Dublin, Ireland. More information about Aralez can be found at

Aralez Pharmaceuticals US Inc. Contact:

Nichol L. Ochsner 
Executive Director, Investor Relations & Corporate Communications 



SOURCE Aralez Pharmaceuticals Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890